Skip to main content
OpenTrials
Completed

NCT Number: NCT02674607

the Potential Immunomodulatory Effects of Spirulina on Thalassemic Children

The aim of this study is to evaluate the possible immunologic effects of spirulina in children with beta thalassemia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Beta Thalassemia Major Anemia Anemia, Hemolytic Anemia, Hemolytic, Congenital Congenital, Hereditary, and Neonatal Diseases and Abnormalities Genetic Diseases, Inborn Hematologic Diseases Hemic and Lymphatic Diseases Hemoglobinopathies Thalassemia beta-Thalassemia

Age range

4 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Medicine- Tanta University

Tanta, Gharbia Governorate, 0000, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • children with thalassemia major

Exclusion criteria

  • children with other chronic hemolytic anemias

Treatment and study plan

Spirulina

Dietary Supplement

Primary outcomes

  1. cluster of differentiation (CD4/CD25) ratio

    Time frame: 3 months

  2. cluster of differentiation (CD33/CD11b/Lin) ratio

    Time frame: 3 months

  3. serum immunoglobulins levels

    Time frame: 3 months

  4. serum levels of interferon gamma

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Tanta University

Other

Registry information

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Feb 4, 2016
Registry last updated
Oct 25, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.